UNION CITY, Calif., Feb. 27 /PRNewswire-FirstCall/ -- Abaxis, Inc. (NASDAQ:ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, CEO and President, will present at the Susquehanna Financial Group's Second Annual SIGnificant Options in Healthcare Conference on Wednesday, March 5, 2008 at 8:00 a.m. ET. The conference will be held at the W New York Hotel, 49th and Lexington Ave., New York, NY.
About Abaxis Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.
Contact: Clint Severson Lytham Partners, LLC
Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum
ABAXIS, Inc. 602-889-9700
510-675-6500
DATASOURCE: Abaxis, Inc.
CONTACT: Clint Severson, Chief Executive Officer of ABAXIS, Inc., +1-510-675-6500; or Joe Dorame, Joe Diaz and Robert Blum, all of Lytham Partners, LLC, +1-602-889-9700
|